E

    Eledon Pharmaceuticals Inc (ELDN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.98
    -0.22 (-6.88%)

    Market Cap: $260.04M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    58%(22/38)
    Avg Surprise
    -4.37%
    Streak
    1 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.19
    Range$-0.21 - $-0.15
    4 analysts
    EPS Revisions
    2
    0
    7d
    2
    0
    30d
    EPS Estimate Drift
    90d ago$-0.18+5.3%
    60d ago$-0.18+2.6%
    30d ago$-0.18+2.6%
    7d ago$-0.18+2.6%
    Current$-0.19
    Revenue Consensus
    $0
    Range$0 - $0
    5 analysts
    Dec 31, 2026
    EPS Consensus$-0.36
    Range$-0.47 - $-0.20
    4 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.36---
    Sep 26EST
    		-$-0.19---
    Jun 26
    		$-0.19$-0.19+0.00%Beat-46.2%
    Mar 26
    		$-0.33$-0.26-26.92%Miss-312.5%
    Dec 25
    		$-0.10$-0.20+50.00%Beat+89.4%
    Sep 25
    		$-0.21$-0.25+16.00%Beat+34.4%
    Jun 25
    		$-0.13$-0.23+43.48%Beat+87.7%
    Mar 25
    		$-0.08N/A+73.33%Beat+76.5%
    Dec 24
    		$-0.95$-0.33-189.44%Miss-226.1%
    Sep 24
    		$-0.32$-0.31-3.23%Miss+8.6%
    Jun 24
    		$-1.06$-0.32-231.25%Miss-165.0%
    Mar 24
    		$-0.34$-0.33-3.03%Miss+54.7%
    Dec 23
    		$-0.29$-0.39+25.64%Beat+58.0%
    Sep 23
    		$-0.35$-0.41+14.63%Beat+52.1%
    Jun 23
    		$-0.40$-0.45+11.11%Beat+38.5%
    Mar 23
    		$-0.75$-0.74-1.35%Miss-8.7%
    Dec 22
    		$-0.69$-0.70+1.43%Beat-15.0%
    Sep 22
    		$-0.73$-0.69-5.80%Miss-10.6%
    Jun 22
    		$-0.65$-0.72+9.72%Beat-30.0%
    Mar 22
    		$-0.69$-0.68-1.47%Miss-21.1%
    Dec 21
    		$-0.60$-0.79+24.05%Beat+13.0%
    Sep 21
    		$-0.66$-0.65-1.54%Miss+88.0%
    Jun 21
    		$-0.50N/A+86.70%Beat+81.5%
    Mar 21
    		$-0.57$-0.32-78.13%Miss+83.7%
    Dec 20
    		$-0.69N/A+60.80%Beat+78.7%
    Sep 20
    		$-5.51$-1.75-214.86%Miss-39.1%
    Jun 20
    		$-2.70$-2.97+9.09%Beat+57.1%
    Mar 20
    		$-3.49$-2.88-21.18%Miss+62.7%
    Dec 19
    		$-3.24$-4.68+30.77%Beat+63.3%
    Sep 19
    		$-3.96$-7.29+45.68%Beat+40.5%
    Jun 19
    		$-6.30$-7.65+17.65%Beat-2.9%
    Mar 19
    		$-9.36$-8.73-7.22%Miss-44.4%
    Dec 18
    		$-8.82$-7.20-22.50%Miss-14.0%
    Sep 18
    		$-6.66$-7.20+7.50%Beat+72.0%
    Jun 18
    		$-6.12$-5.58-9.68%Miss+77.8%
    Mar 18
    		$-6.48$-5.22-24.14%Miss+76.5%
    Sep 17
    		$-7.74N/AN/ABeat+88.3%
    Jun 17
    		$-23.76N/A+51.11%Beat-
    Mar 17
    		$-27.54$-48.60+43.33%Beat-
    Dec 16
    		$-27.54$-55.08+50.00%Beat-
    Sep 16
    		$-66.42$-68.85+3.53%Beat-

    Key Metrics

    Valuation
    P/E Ratio-3.59EV/EBITDA0.84x
    Price/FCF-4.58xFCF Yield-21.81%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-110.70%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio7.90xQuick Ratio7.90x
    Trading Statistics
    Beta0.96Avg Volume948.80K
    52-Week High$4.6052-Week Low$1.35

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.39
    SMA 20$3.50
    SMA 50$3.68
    SMA 200$2.90
    EMA 10$3.33
    EMA 20$3.45
    EMA 50$3.56
    EMA 200$3.28

    MACD

    Line: -0.12Signal: -0.08Hist: -0.05

    ADX

    ADX: 16.6+DI: 13.7-DI: 32.4

    Aroon & PSAR

    Aroon Up40.0
    Aroon Down100.0
    PSAR$3.66

    Bollinger Bands

    Upper Band$3.88
    Lower Band$3.11
    %B Position2197%(Upper)
    Band Width-0.17

    RSI (14-Day)

    Oversold
    27.8

    Momentum Oscillators

    Stoch %K7.4
    Stoch %D12.4
    Williams %R-94.1
    ROC (10d)-16.8%
    Momentum-0.60
    CCI (20d)-233.4
    MFI (14d)20.6

    Volatility Measures

    ATR (14d)$0.19(6.4%)
    StdDev (20d)0.19
    Hist Vol45.4%(High)

    Volume Flow

    VWAP$3.02
    OBV6.1M
    AD Line-13.6M
    CMF (20d)-0.169

    Volume Metrics

    Avg Vol (20d)916.2K
    Vol Ratio2.0x(High)
    VWMA (20d)$3.46

    Pivot Points

    R3$3.44
    R2$3.38
    R1$3.29
    Pivot Point$3.23
    S1$3.14
    S2$3.08
    S3$2.99

    Advanced Oscillators

    TSI-20.76
    Ultimate Osc35.5
    KST-72.24

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$384,000$0$0$0$0$0
    Cost of Revenue$0$0N/A$0$0$0$88,000$0$0$0$94,000$0
    Gross Profit$0$0N/A$0$0$0$-88,000$0$0$0$-94,000$0
    Operating Expenses$22.87M$21.18M$21.48M$19.07M$24.73M$17.96M$24.70M$20.51M$14.50M$10.87M$10.34M$11.20M
    R&D$18.23M$17.20M$17.49M$14.97M$20.28M$13.53M$17.93M$16.52M$10.11M$7.41M$7.07M$7.93M
    SG&A$4.64M$3.98M$3.99M$4.10M$4.46M$4.43M$6.77M$3.99M$4.40M$3.46M$3.27M$3.27M
    Operating Income$-22,869,000$-21,181,000$-21,484,000$-19,070,000$-24,733,000$-17,964,000$-24,696,000$-20,510,000$-14,502,000$-10,869,000$-10,338,000$-11,198,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$8.76M$17.84M$0$0$0$0$19.49M$0$30.41M$12.76M$18.99M$0
    Income Before Tax$-31,630,000$-39,025,000$-10,412,000$-17,459,000$-11,216,000$-6,495,000$-44,186,000$76.97M$-44,907,000$-23,631,000$-29,324,000$-9,906,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-31,630,000$-39,025,000$-10,447,000$-17,459,000$-11,216,000$-6,495,000$-44,617,000$76.97M$-44,907,000$-23,631,000$-30,099,000$-9,906,000
    EBITDA$-31,630,000$-39,025,000$-10,412,000$-17,459,000$-11,216,000$-6,495,000$-44,186,000$76.97M$-44,907,000$-23,631,000$-29,230,000$-9,812,000
    EBIT$-31,630,000$-39,025,000$-10,412,000$-17,459,000$-11,216,000$-6,495,000$-44,186,000$76.97M$-44,907,000$-23,631,000$-29,324,000$-9,906,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ELDN

    News

    Eledon Pharmaceuticals (NASDAQ:ELDN) Upgraded at Wall Street Zen

    Wall Street Zen upgraded Eledon Pharmaceuticals (NASDAQ:ELDN) from "strong sell" to "sell," though the broader analyst consensus remains "Hold" with a $9.67 target price. The company reported a quarterly loss of $0.27 per share, missing estimates, and its shares opened at $3.54. Institutional investors hold 56.77% of the stock, with several firms recently initiating or increasing their positions.

    MarketBeat•8/15/26•
    Neutral

    Noble Financial Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Maintains Target Price $10

    Noble Financial has reiterated its Buy rating on Eledon Pharmaceuticals (ELDN.US) and maintained a target price of $10. This indicates a continued positive outlook from the firm regarding the company's stock performance.

    Moomoo•8/14/26•
    Bullish

    Eledon Pharmaceuticals (NASDAQ:ELDN) Posts Quarterly Earnings Results, Misses Expectations By $0.11 EPS

    Eledon Pharmaceuticals (NASDAQ:ELDN) reported a quarterly loss of $0.27 per share, missing the consensus estimate by $0.11. The stock subsequently fell 1.9% to $3.70, with a consensus "Hold" rating and an average price target of $9.67 from analysts. Institutional investors hold a significant portion of the company's shares, with some recently increasing their positions.

    MarketBeat•8/14/26•
    Bearish

    Eledon Pharmaceuticals Reports Q2 2026 Form 10-Q Highlighting Going Concern and Funding Challenges

    Eledon Pharmaceuticals' Q2 2026 Form 10-Q filing reveals significant concerns about its ability to continue as a going concern due to ongoing operating losses and the critical need for additional financing. The company anticipates continued losses and warns that failure to secure more capital could lead to scaling back or halting operations, potentially diluting current shareholders if new stock is issued.

    Kalkine Media•8/13/26•
    Bearish

    Form 8K Eledon Pharmaceuticals Inc For: 13 August By Investing.com

    This article reports on the filing of Form 8K by Eledon Pharmaceuticals Inc. for August 13. It includes a brief mention of the company's stock symbol (ELDN) and its current performance (-4.62%), alongside general market data and other news headlines.

    Investing.com UK•8/13/26•
    Neutral

    Frequently Asked Questions About ELDN

    Does ELDN pay dividends?
    Eledon Pharmaceuticals Inc (ELDN) does not currently pay a regular dividend.
    What is ELDN's market cap?
    Eledon Pharmaceuticals Inc (ELDN) has a market capitalization of $260.04M with a current stock price of $2.98.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In